Stay updated on Nivolumab and RT in Localized Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    This page update includes a new revision tag (v3.4.2) and removal of older revision notices (v3.4.1) and a government-funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:00:48.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding notice was added stating NIH Clinical Center is open and updates can be found at opm.gov, and the page version was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:32:21.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and updates several page-labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision tag to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:36:44.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The changes consist of revision metadata (Revision: v3.3.4 and the previous v3.3.3) and do not modify any study content, eligibility criteria, or results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Michigan and New York as study sites and removed the separate Michigan Locations and New York Locations sections. The footer now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.3%
    Check dated 2025-12-23T17:21:33.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page shows a minor site revision update from v3.2.0 to v3.3.2, with no visible changes to the study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:15:31.000Z thumbnail image

Stay in the know with updates to Nivolumab and RT in Localized Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.